Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599794 · ClinicalTrials.gov registry record
A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 84
- Enrollment target
NCT00599794: Completed study, sponsored by Mayo Clinic.
NCT00599794 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599794 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
Patients may have actual or relative intravascular volume depletion in a number of different disease states, particularly with sepsis syndrome. However, it is clinically difficult to determine volume status without invasive monitoring, which may cause unintended complications. Our hypothesis is that we can accurately estimate central venous pressure, which is a surrogate marker of volume status, with a noninvasive portable ultrasound device.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-01 |
What the finished NCT00599794 record still lists
NCT00599794 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00599794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00599794 about?
NCT00599794 is a clinical study titled "A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status". Patients may have actual or relative intravascular volume depletion in a number of different disease states, particularly with sepsis syndrome. However, it is clinically difficult to determine volume status without invasive monitoring, which may cause unintended complications. Our hypothesis is that...
What is the current status of trial NCT00599794?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2006-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00599794?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia